image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SigmaRoc - Shares race to £1

June 2025

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SRC
  • Price:
  • 97.5p
The shares hit a new high of 100p after SigmaRoc’s Q1 results revealed revenues and EBITDA marginally ahead of expectations at £252m and £49m, representing year-on-year growth of 18% and 30%, respectively. EBITDA grew 1.3% excluding the CRH acquisition. Growth was driven by a marginal increase in high grade mineral volumes, as well as product mix and network optimisation and acquisition synergies. Zeus’ unchanged forecast is for EBITDA of £248m, £268m and £279m between FY’25-’27 for eps of 8.8p, 10.2p and 11p and says the shares have re-rating potential based on further de-leveraging (with leverage forecast to reduce from 2.1x to 1.7x this year) and the possibility of cost synergies being higher than the €60m target. Zeus’ price t ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe